|
Depression is a significant
predictor of worse quality of life and perceived shortness of
breath in patients awaiting lung transplantation, according to
Duke University researchers.
The researchers report
the negative effects of depression are above and beyond other
factors, such as lung function and the underlying disease, and
believe that efforts to treat depression might improve outcomes
after lung transplantation.
"These findings
represent an example of how psychological factors can impact physical
health," said Dr. Scott Palmer, medical director of Duke's
lung transplantation program. "The effect of depression is
quite striking in predicting a lung patient's quality of life
as well as their perceived shortness of breath."
"The
findings also suggest that while we have many medical treatments
for these patients, if we don't address the issue of anxiety and
depression we might have less impact on their quality of life,
and possibly their ultimate outcomes," Palmer added.
Palmer prepared
the results of the Duke study for presentation at the 98th annual
international conference of the American Thoracic Society.
Their report
is the first analysis of data being collected on patients awaiting
lung transplants enrolled in a five-year, $2.6 million trial funded
by the National Heart, Lung and Blood Institute. For this "snapshot"
of the psychological and physical status of the first 99 patients
enrolled in the trial on Duke's waiting list, patients took a
battery of tests to measure their depression and anxiety.
"Our
analysis suggests that while lung function and underlying disease
are important predictors of pulmonary quality of life and shortness
of breath, depression appears to be a stronger predictor,"
Palmer said. "We need more studies to evaluate different
interventions to see if they have any impact on quality of life
and post-transplant outcomes."
Other
sources: Duke University
|